Working... Menu

Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00003232
Recruitment Status : Completed
First Posted : April 9, 2004
Last Update Posted : November 9, 2010
Information provided by:
Canadian Cancer Trials Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2009
  Actual Study Completion Date : February 2009
Publications of Results:
Taylor SK, Ding K, Ernst SD, et al.: Palliative response measurement in a phase III study of patients with prostate cancer and painful bone metastases: secondary analysis of NCIC-CTG PR6. [Abstract] J Clin Oncol 26 (Suppl 15): A-9636, 2008.